11
Views
4
CrossRef citations to date
0
Altmetric
Research Article

The generation of the F2-isoprostane 8-epi-PGF2alpha by human platelets on collagen stimulation

Pages 253-256 | Published online: 07 Jul 2009

  • Morrow JD, Hill KE, Burk RF, Nammour TM, Badr KF, Roberts LJ. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclo-oxygenase, free radical catalysed mechanism. Proc Natl Acad Sci USA 1990; 87: 9383-7.
  • Takahashi K, Nammour TM, Fukunaga M, Ebert J, Morrow JD, Roberts LJ, Hoover RL, Badr KF. Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2n, in the rat. J Clin Invest 1992; 90: 136-41.
  • Banerjee M, Kang KH, Morrow JD, Roberts LJ, Newman JH. Effects of a novel prostaglandin, 8-CpI-PGF2n, in rabbit lung in situ. Am J Physiol 1992; 263: H660-3.
  • Fukunaga M, Makita N, Roberts LJ, Morrow JD, Takahashi K, Badr KF. Evidence for the existence of F2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol 1993; 264: C1619-24.
  • Morrow JD, Minton TA, Roberts LJ. The F2-isoprostane 8-epiprostaglandin F201, a potent agonist of the vascular thromboxane/ endoperoxide receptor is a platelet thromboxane/endoperoxide receptor antagonist. Prostaglandins 1992; 44: 155-63.
  • Gopaul NK, Nourooz-Zadeh J, Mallet AI, Anggard EE. Formation of PGF2-isoprostanes during the oxidative modification of low density lipoprotein. Biochem Blophys Res Commun 1994; 200: 338-43.
  • Gopaul NK, Nourooz-Zadeh J, Mallett AI, Anggard EE. Formation of F2-isoprostanes during aortic endothelial cell-mediated oxidation of low density lipoprotein. FEBS Letts 1994; 348: 297-300.
  • Morrow JD, Frei B, Longmire AW, Gaziano JM, Lynch SM, Shyr Y, Strauss WE, Gates JA, Roberts LJ. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. N Engl J Med 1995; 332: 1198-203.
  • Gopaul NK, Änggård EE, Mallet AI, Betteridge DJ, WoIff SP, Nourooz-Zadeh J. Plasma 8-epi-PGF2a levels are elevated in individuals with non-insulin dependent diabetes mellitus. FEBS Letts 1995; 368: 225-9.
  • Davi G, Alessandrini P, Mezzetti A, Minotti G, Buccianelli T, Costantini F, Cipollone F, Bon GB, Ciabattoni G, Patrono C. In vivo formation of 8-epi-prostaglandin F2a is increased in hypercholesterolaemia. Arterioscler Thromb Vase Biol 1997; 17: 3230-5.
  • Catella F, Reilly M P, Delanty N, Lawson JA, Moran N, Meagher E, Fitzgerald GA. Physiological formation of 8-CpI-PGF2a in vivo is not affected by cyclooxygenase inhibition. Adv Prostaglandin Thromboxane Leukotriene Res 1995; 23: 233-6.
  • Pratico D, Lawson JA, Fitzgerald GA. Cyclooxygenase-dependent formation of the isoprostane, 8-epi-prostaglandin F2a. J Biol Chem 1995; 270: 9800-8.
  • Nourooz-Zadeh J, Gopaul NK, Barrow S, Mallet AI, Anggard EE. Analysis of F2-isoprostanes as indicators of non-enzymatic lipid peroxidation in vivo by gas chromatography-mass spectrometry: Development of a solid-phase extraction procedure. J Chromatogr 1995; 667: 199-208.
  • Alarayyid NA, Graham BR, Ferdous AH, Betteridge DJ, Prichard BNC, Smith CCT. An examination of some factors which influence the stability of in vitro platelet responses. Platelets 1994; 5: 317-24.
  • Smith CCT. Evidence for separate serotonin and catecholamine compartments in human platelets. Biochim Blophys Acta 1996; 1291: 1-4.
  • Lowry OH, Rosebrough NR, Fair AL, Randall RJ. Protein measurement with the folin-phenol reagent. J Biol Chem 1951; 193: 265-75.
  • Smith CCT, Wilson AP, Betteridge DJ. The influence of aspirin on plasma and platelet catecholamine levels, and platelet function in normal man. Clin Autonom Res 1993; 3: 49-53.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.